White House science/tech panel outlines path for doubling new medicines
This article was originally published in Scrip
Executive Summary
To improve drug discovery and development in the US, the federal government should strongly support funding for basic biomedical research, catalyze the creation of a broad-based partnership to speed therapies to market and expand the use of the FDA's existing authorities for accelerated approval, a panel of advisers to President Barack Obama said in a new report.